以质量求发展，以服务铸品牌

护理学报 ›› 2023, Vol. 30 ›› Issue (22): 56-62.doi: 10.16460/j.issn1008-9969.2023.22.056

• 循证护理 • 上一篇    下一篇

肺癌中医临床疗效评估工具测量学特性的系统评价

魏佳豪1,2, 卜梦茹1, 白子叶1,2, 周瑾1   

  1. 1.南方医科大学中西医结合医院 护理部,广东 广州 510280;
    2.南方医科大学护理学院,广东 广州 510515
  • 收稿日期:2023-06-28 出版日期:2023-11-25 发布日期:2023-12-07
  • 通讯作者: 周瑾（1977-）,女,安徽巢湖人,博士,主任护师,护理部主任,硕士研究生导师。E-mail:727120567@qq.com
  • 作者简介:魏佳豪（1998-）,男,山西吕梁人,本科学历,硕士研究生在读,护士。
  • 基金资助:
    2022年度广东省中医药局科研项目（20221278）

Measurement property of traditional Chinese medicine clinical effectiveness evaluation scales for lung cancer: a systematic review

WEI Jia-hao1,2, BU Meng-ru1, BAI Zi-ye1,2, ZHOU Jin1   

  1. 1. Dept. of Nursing Administration, Integrated Traditional Chinese and Western Medicine Hospital, Southern Medical University, Guangzhou 510280, China;
    2. School of Nursing, Southern Medical University, Guangzhou 510515, China
  • Received:2023-06-28 Online:2023-11-25 Published:2023-12-07

PDF (PC)

112

赞

摘要： 目的 系统评价肺癌中医临床疗效评估工具的测量学特性和相关研究的方法学质量,为医护人员选择高质量的工具提供循证依据。方法 系统检索PubMed、The Cochrane Library、Web of Science、Embase、PsycINFO、CINAHL、中国生物医学文献数据库、中国知网、万方数据库、维普数据库,检索时限为建库至2023年6月。分别采用基于共识的健康测量工具遴选标准（Consensus-based Standards for the Selection of Health Measurement Instruments,COSMIN）偏倚风险清单和量表测量学性能评价标准评定相关工具的方法学质量及测量属性并形成最终推荐意见。结果 最终纳入8个肺癌中医临床疗效评估工具,均未报告测量误差、跨文化效度或测量等同性。结论 现有证据提示肺癌中医临床疗效评估工具测量学特性评价不够全面,总体研究方法学质量偏低,其中基于中医理论的恶性肿瘤生活质量评价体系之肺癌量表（Quality of Life Assessment System for Cancer based on Traditional Chinese Medicine- Lung Cancer,QLASTCM -Lu）研究质量及性能评价尚可,未来应进一步完善和验证现有工具,或重新构建低偏倚风险、高适用性的肺癌中医临床疗效测量工具。

关键词: 肺癌, 中医, 评估工具, 测量学特性, 系统评价

Abstract: Objective To systematically evaluate the measurement properties of TCM clinical efficacy assessment tools for lung cancer and the methodological quality of related studies, and to provide evidence-based reference for healthcare professionals to select high-quality assessment tools. Methods A systematic search was conducted in multiple databases, including PubMed, The Cochrane Library, Web of Science, Embase, PsycINFO, CINAHL, China Biomedical Literature Database, China Knowledge Network, Wanfang Database, and VIP. The retrieval period was from the inception of the databases to June 2023. The methodological quality and measurement properties of the identified tools were assessed using the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN-RoB) and Scale Measurement Performance Evaluation Criteria, respectively. Based on these evaluations, final recommendations were made. Results Eight TCM clinical efficacy evaluation tools for lung cancer were finally included, and no measurement error, cross-cultural validity and measurement equivalence were reported. Conclusion The existing evidence suggests that TCM clinical efficacy evaluation tools for lung cancer could not provide comprehensive assessment, and the overall research methodology quality is low. Relatively, the research quality and performance evaluation of Quality of Life Assessment System for Cancer based on Traditional Chinese Medicine- Lung Cancer (QLASTCM-Lu) is still acceptable. In the future, the existing tools should be further improved and validated, or a new TCM clinical efficacy measurement tool for lung cancer with low-bias risk and high-applicability should be constructed.

Key words: lung cancer, traditional Chinese medicine, assessment tool, measurement property, systematic review

中图分类号: 

  • R473.73
[1] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI:10.3322/caac.21492.
[2] Wei Z, Chen J, Zuo F, et al.Traditional chinese medicine has great potential as candidate drugs for lung cancer: a review[J]. J Ethnopharmacol, 2023(300): 115748. DOI:10.1016/j.jep.2022.115748.
[3] 李凯, 张俊华, 张明妍, 等.中医药核心指标集(COS-TCM)研究现状[J]. 世界科学技术-中医药现代化, 2021, 23(8): 2556-2562. DOI:10.11842/wst.20210525013.
[4] 于长禾, 孙亚男, 何丽云, 等. 中医普适性生活质量量表的系统评价[J]. 中华中医药杂志, 2016, 31(2): 432-437.
[5] 张艳宏,刘保延,刘志顺,等. PRO与中医临床疗效评价[J]. 中医杂志,2007(8):680-682.DOI:10.13288/j.11-2166/r.2007.08.003.
[6] 包瑜, 张培彤. 原发性支气管肺癌中医证候研究现状评述[J]. 环球中医药, 2022, 15(7): 1273-1279.
[7] Prinsen CAC, Mokkink LB, Bouter LM, et al.COSMIN guideline for systematic reviews of patient-reported outcome measures[J]. Qual Life Res, 2018, 27(5): 1147-1157. DOI:10.1007/s11136-018-1798-3.
[8] Terwee CB, Mokkink LB, Knol DL,et al.Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist[J].Qual Life Res, 2012,21(4):651-657.DOI:10.1007/s11136
-011-9960-1.
[9] Terwee CB, Bot S DM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires[J]. J Clin Epidemiol, 2007, 60(1):34-42.DOI:10.1016/j.jclinepi.2006.03.012.
[10] Terwee CB, Prinsen CAC Chiarotto A, et al.COSMIN methodology for assessing the content validity of PROMs user manual v1.pdf[EB/OL].[2023-06-20]. https://cosmin.nl/wp-content/uploads/COSMIN-methodology-for-content-validity-user-manual-v1.pdf.
[11] McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate?[J]. Qual Life Res, 1995, 4(4):293-307. DOI:10.1007/BF01593882.
[12] 陈祎婷, 沈蓝君, 彭健, 等. 改良版定量系统评价证据分级方法对患者报告结局测量工具的评价[J]. 解放军护理杂志, 2020, 37(10):57-60. DOI:10.3969/j.issn.1008-9993.2020.10.014.
[13] 于莉, 张会永, 王佳楠, 等. 基于患者报告结局的气虚证中医疗效评价量表考评[J]. 上海中医药杂志, 2020, 54(9): 60-64. DOI:10.16305/j.1007-1334.2020.1910103.
[14] 陈玉招. 气虚证自评量表的初步研制及考评[D]. 福州:福建中医药大学, 2016.
[15] Wan C, You S, Quan P, et al. Development and validation of the quality-of-life assessment system for lung cancer based on traditional chinese medicine[J]. Evid Based Complement Alternat Med, 2012(2012): 945910.0. DOI: 10.1155/2012/945910.
[16] Wang TT, He LY, Zhang M, et al.Development of improved version of quality of life assessment instrument for lung cancer patients based on traditional chinese medicine (QLASTCM-Lu)[J]. Chin J Integr Med, 2019, 25(11): 831-836. DOI:10.1007/s11655-018-2991-5.
[17] 刁佳. 中晚期肺癌患者中医生存质量量表(QOL-AL)的研究[D]. 南京:南京中医药大学, 2007.
[18] 张星辉. 肺系病证自评量表的初步研制及考评[D]. 福州:福建中医药大学, 2016.
[19] 杨可鑫. 阴虚证中医疗效评价量表的研制与考评[D]. 沈阳:辽宁中医药大学, 2018.
[20] 熊丽枚. 阴虚证自评量表的初步研制及考评[D]. 福州:福建中医药大学, 2016.
[21] 施月仙, 张海明, 黄亚琪, 等. 选择健康测量工具的共识标准(COSMIN)偏倚风险评价清单的解读[J]. 中国护理管理,2021,21(7):1053-1057.DOI:10.3969/j.issn.1672-1756.2021.07.018.
[22] Terwee CB, Prinsen Ca.C, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study[J]. Qual Life Res, 2018, 27(5): 1159-1170. DOI:10.1007/s11136-018-1829-0.
[23] 陈祎婷, 彭健, 沈蓝君, 等. COSMIN方法介绍:结合一项系统评价实例进行解读[J].护理研究, 2021, 35(9): 1505-1510. DOI:10.12102/j.issn.1009-6493.2021.09.001.
[24] 徐孟娇, 金潇, 袁文雯, 等. 基于贝叶斯网络与关联规则探讨下肢动脉硬化闭塞症的中医临床疗效评价条目[J]. 中医杂志, 2023, 64(12):1218-1224. DOI:10.13288/j.11-2166/r.2023.12.007.
[25] 王寅, 吴朝旭, 王玥, 等. 基于现代医学诊疗模式的非小细胞肺癌中医证型梳理与浅析[J]. 天津中医药, 2020, 37(10): 1195-1200. DOI:10.11656/j.issn.1672-1519.2020.10.25.
[26] 张成果, 孙小玲, 卢山, 等. 患者重症监护体验测量工具的范围综述[J]. 护理学报, 2022, 29(18): 53-58.DOI:10.16460/j.issn1008-9969.2022.18.053.
[27] 彭健, 沈蓝君, 陈祎婷, 等. 对COSMIN-RoB清单中测量工具稳定性、测量误差和效标效度研究偏倚风险的清单解读[J]. 中国循证医学杂志, 2020, 20(11): 1340-1344.
[28] Moreira RSL, Bassolli L, Coutinho E, et al.Reproducibility and reliability of the quality of life questionnaire in patients with atrial fibrillation[J]. Arq Bras Cardiol, 2016, 106(3): 171-181. DOI: 10.5935/abc.20160026.
[29] Health measurement scales: a practical guide to their development and use(5th edition)[J].Aust N Z J Public Health, 2016, 40(3): 294-295. DOI:10.1111/1753-6405.12484.
[30] 高云, 赵俊峰, 徐丽丽, 等. COSMIN 操作指南对中文版电子健康素养量表的评价[J]. 中国老年学杂志, 2020, 40(9): 1968-1973.
[31] 茅范贞, 韩耀风, 方亚. 量表条目的统计学筛选方法研究进展[J]. 现代预防医学, 2015, 42(1): 1-3.
[32] Edelen MO, Reeve BB.Applying item response theory (IRT) modeling to questionnaire development, evaluation,refinement[J]. Qual Life Res, 2007, 16 Suppl 1(1): 5-18. DOI: 10.1007/s11136-007-9198-0.
[33] Mokkink LB, de Vet HCW, Prinsen Ca.C, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures[J]. Qual Life Res, 2018, 27(5): 1171-1179. DOI:10.1007/s11136-017-1765-4.
[1] 朱明月, 丁晓彤, 史纪元, 李峥. 自我感知老化对老年人认知功能影响的系统评价[J]. 护理学报, 2023, 30(8): 52-57.
[2] 郑静, 管玉香, 张瑛, 许娟, 邹冉, 王超. 安徽省873名中医院护士长变革型领导力影响因素分析[J]. 护理学报, 2023, 30(7): 16-19.
[3] 李姗姗, 黄红艳, 李媛媛, 黎江静. 终末期慢性肾脏病患者治疗决策需求的研究进展[J]. 护理学报, 2023, 30(7): 38-43.
[4] 叶磊, 张爱琴, 荣芸, 夏广惠. 老年髋部骨折患者术后谵妄风险预测模型的系统评价[J]. 护理学报, 2023, 30(7): 48-52.
[5] 陶娟, 潘红英, 陈慧颖, 蓝莹, 鲜雪梅. 医务人员手卫生评估工具的研究进展[J]. 护理学报, 2023, 30(6): 26-30.
[6] 杨楠楠, 蒋慧萍, 史婷奇. 基于机器学习构建住院患者深静脉血栓风险预测模型的系统评价[J]. 护理学报, 2023, 30(23): 44-49.
[7] 熊尹诗, 王娜, 张颖. 基于奥马哈问题分类系统构建吞咽障碍老年患者护理问题评估体系[J]. 护理学报, 2023, 30(23): 67-72.
[8] 王窈, 管玉香, 郑静, 许娟, 王超. 持续血糖监测在糖尿病患者中应用的系统评价再评价[J]. 护理学报, 2023, 30(21): 39-45.
[9] 朱明月, 史纪元, 李峥. 计算机化认知训练对认知功能障碍患者干预效果的系统评价再评价[J]. 护理学报, 2023, 30(21): 46-53.
[10] 万丽丽, 宋春美, 郑翠霞. 消化性溃疡患者自我报告结局评估工具的研究进展[J]. 护理学报, 2023, 30(19): 37-40.
[11] 张馥丽, 王丹妮, 叶红, 蔡姣芝. 胃癌患者报告结局评估工具的研究进展[J]. 护理学报, 2023, 30(19): 41-44.
[12] 周飞洋, 邓露, 龙柯宇, 杨婷婷, 谢琳琳, 吕倩, 郭春波. 老年人认知衰弱风险预测模型的系统评价[J]. 护理学报, 2023, 30(19): 45-50.
[13] 董岩, 朱思颖, 王虹, 范甜甜, 黎玉梅, 韩媛. 青少年癌症幸存者重返校园体验质性研究的Meta整合[J]. 护理学报, 2023, 30(19): 56-61.
[14] 骆佳慧, 罗园园, 方庆虹, 叶艳欣, 刘素婷, 杨智慧, 缪景霞, 张立力. 肺癌患者认知功能的现状及影响因素分析[J]. 护理学报, 2023, 30(18): 1-5.
[15] 崔静萍, 蒋燕, 赵姗姗. 衰弱和抑郁在肺癌化疗患者恐惧疾病进展与生活质量间的链式中介作用[J]. 护理学报, 2023, 30(18): 65-70.
Viewed
Full text


Abstract

Cited
  Shared   
[1] 马瑞英,李亚洁. 美国疾病诊断相关组法护理支付方式对我国护理收费的启示[J]. 护理学报, 2012, 19(1): 23 -25 .
[2] 周玥,张淼,赵江,李成. 胃肠道肿瘤患者生命质量影响因素研究现状及思考[J]. 护理学报, 2012, 19(1): 26 -28 .
[3] 曾友燕,徐燕,储静,顾申. 护理专业课程实行主讲教师负责制的教学实践与效果分析[J]. 护理学报, 2012, 19(1): 29 -31 .
[4] 宁宁,陈佳丽,朱红,马莉. 项目管理理论在医院护理创新管理中的应用[J]. 护理学报, 2012, 19(1): 32 -35 .
[5] 马逊,朱亚梅,吕小林,张静,王蓉花,王玲. 不同血液透析预冲方法对透析器凝血的影响[J]. 护理学报, 2012, 19(1): 42 -44 .
[6] 马婕,魏建华,白茹,雍琪. 1例重度卢德维氏咽峡炎患者的护理[J]. 护理学报, 2012, 19(1): 51 -52 .
[7] 徐建平,金慧,章功年. 经脐一孔法腹腔镜胆囊切除术的护理配合[J]. 护理学报, 2012, 19(1): 56 -58 .
[8] 蒋凤莲,常后婵,刘沛珍. 11例术后患者石蜡油致乳胶导尿管脱出原因分析[J]. 护理学报, 2012, 19(1): 63 -64 .
[9] 揭小燕. A型肉毒毒素注射治疗患者的护理[J]. 护理学报, 2012, 19(1): 65 -66 .
[10] 吕娟,宁宁,叶霞,廖灯彬,陈佳丽. 某院85名伤口治疗护士伤口疼痛认知及管理情况分析[J]. 护理学报, 2012, 19(1): 1 -4 .